XERIS PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 29th, 2021 • Xeris Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
This Employment Agreement (“Agreement”) is made as of the 28th day of July 2021, between Xeris Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Steven Pieper (the “Executive”) and is effective as of the date written above (the “Effective Date”).
July 28, 2021 Dear Barry:Xeris Pharmaceuticals Inc • July 29th, 2021 • Pharmaceutical preparations • Illinois
This letter confirms that your employment at Xeris Pharmaceuticals, Inc. (the “Company”) will end on the closing date of the transactions contemplated by the Transaction Agreement by and among the Company, Strongbridge Biopharma plc and the other parties set forth therein dated May 24, 2021 (the “Transactions”). The closing date of the Transactions or, if no closing has yet occurred, October 29, 2021, is referred to herein as the “Anticipated Date of Termination.” The actual last day of your employment is referred to herein as the “Date of Termination”, and the time period between the date of this letter and the Date of Termination is the “Transition Period.”
